Page last updated: 2024-08-21

vancomycin and Inflammatory Response Syndrome, Systemic

vancomycin has been researched along with Inflammatory Response Syndrome, Systemic in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (30.77)29.6817
2010's9 (69.23)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, TA; Dey, D; Forsberg, JA; Hanson, MA; Moss, KL; Pavey, GJ; Potter, BK; Qureshi, AT; Sanders, EM; Seavey, JG; Tomasino, AM; Wheatley, BM1
Imai, T1
Habib, S; Hsu, CH; Patel, N; Patel, S; Schader, L; Twesigye, I; Walker, C; Yarlagadda, S1
Aswapokee, N; Kiratisin, P; Rattanaumpawan, P; Ussavasodhi, P1
Fukuda, T; Komori, K; Sadamitsu, D; Shimamoto, Y; Tanaka, K1
Cho, MH; Ha, YE; Kim, DH; Kong, KH; Song, YS; Yoon, SY1
Imai, T; Irikuchi, J; Orii, T; Yoshida, Y1
Dryden, M; Gonzalez, J; Iaconis, JP; Wilson, D; Zhang, Y1
Chuma, M; Imai, T; Kaburaki, M; Kikuchi, N; Kinoshita, K; Makishima, M; Sakaue, T; Tochikura, N; Yoshida, Y1
Boucher, HW; Campion, M; Corey, GR; Fowler, VG; Kanafani, ZA; Katz, DE; Kourany, WM; Levine, DP; Vigliani, GA1
Butt, T; Karamat, KA; Mahmood, A1
Diallo, HM; Diop, BM; Hatim, B; Seydi, M; Soumaré, M; Sow, AI; Sow, PS; Tine, R1
Bar, K; Bearman, GM; Edmond, MB; Wenzel, RP; Wisplinghoff, H1

Reviews

1 review(s) available for vancomycin and Inflammatory Response Syndrome, Systemic

ArticleYear
[Evaluation of Pharmacotherapy on Emergency and Intensive Care Medicine: The Influence of Intensity and Duration of Invasion].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2017, Volume: 137, Issue:12

    Topics: Critical Care; Critical Illness; Drug Monitoring; Drug Therapy; Emergency Medical Services; Humans; Phenytoin; Systemic Inflammatory Response Syndrome; Vancomycin

2017

Trials

2 trial(s) available for vancomycin and Inflammatory Response Syndrome, Systemic

ArticleYear
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:12

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Systemic Inflammatory Response Syndrome; Treatment Outcome; Vancomycin; Young Adult

2016
Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2009, Volume: 28, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Daptomycin; Diabetes Complications; Endocarditis, Bacterial; Female; Gentamicins; Humans; Male; Middle Aged; Penicillins; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Systemic Inflammatory Response Syndrome; Treatment Outcome; Vancomycin

2009

Other Studies

10 other study(ies) available for vancomycin and Inflammatory Response Syndrome, Systemic

ArticleYear
Early local delivery of vancomycin suppresses ectopic bone formation in a rat model of trauma-induced heterotopic ossification.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2017, Volume: 35, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cell Proliferation; Cytokines; Drug Evaluation, Preclinical; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Ossification, Heterotopic; Rats, Sprague-Dawley; Soft Tissue Infections; Staphylococcal Infections; Systemic Inflammatory Response Syndrome; Vancomycin; Wounds and Injuries; X-Ray Microtomography

2017
Safety and efficacy of antibiotics among acutely decompensated cirrhosis patients.
    Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:11

    Topics: Acute-On-Chronic Liver Failure; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cohort Studies; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk; Survival Rate; Systemic Inflammatory Response Syndrome; Treatment Outcome; Vancomycin

2018
Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria.
    BMC infectious diseases, 2013, Apr-08, Volume: 13

    Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Prevalence; Risk; Survival Analysis; Systemic Inflammatory Response Syndrome; Thailand; Vancomycin

2013
Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis.
    Intensive care medicine, 2013, Volume: 39, Issue:7

    Topics: Adult; Age Factors; Anti-Bacterial Agents; Bayes Theorem; Dose-Response Relationship, Drug; Female; Humans; Linear Models; Male; Metabolic Clearance Rate; Middle Aged; Multivariate Analysis; Systemic Inflammatory Response Syndrome; Vancomycin

2013
Vancomycin blocks autophagy and induces interleukin-1β release in macrophages.
    The Journal of antibiotics, 2015, Volume: 68, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Autophagy; Cell Line; Humans; Inflammation; Interleukin-1beta; Lipopolysaccharides; Macrophages; Mice; Sepsis; Systemic Inflammatory Response Syndrome; Vancomycin

2015
[Influence of systemic inflammatory response syndrome on the pharmacokinetics of vancomycin].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2015, Volume: 135, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Middle Aged; Systemic Inflammatory Response Syndrome; Vancomycin

2015
Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis.
    Clinical therapeutics, 2016, Volume: 38, Issue:12

    Topics: Adult; Aged; Anti-Bacterial Agents; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; ROC Curve; Sepsis; Staphylococcal Infections; Systemic Inflammatory Response Syndrome; Time Factors; Vancomycin

2016
Neonatal sepsis: high antibiotic resistance of the bacterial pathogens in a neonatal intensive care unit in Karachi.
    JPMA. The Journal of the Pakistan Medical Association, 2002, Volume: 52, Issue:8

    Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Systemic Inflammatory Response Syndrome; Vancomycin

2002
[Staphylococcus aureus bacteremia in the Dakar Fann University Hospital].
    Medecine et maladies infectieuses, 2004, Volume: 34, Issue:5

    Topics: Adult; Aged; Bacteremia; Comorbidity; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; HIV Infections; Hospitals, University; Humans; Inpatients; Male; Methicillin Resistance; Middle Aged; Prevalence; Retrospective Studies; Senegal; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Systemic Inflammatory Response Syndrome; Vancomycin

2004
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
    BMC infectious diseases, 2006, Sep-26, Volume: 6

    Topics: Adult; Bacteremia; Cross Infection; Enterococcus; Humans; Systemic Inflammatory Response Syndrome; Vancomycin; Vancomycin Resistance

2006